slides · global inventory
Summarize
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 42,035
Current window 21,421-21,450
Pages 1,402
Rows per page 30
Slide function
21,421-21,450 of 42,035
16
Apollo Global Management | Mergers and Acquisitions Presentation Deck | 36 slidesApollo Global Management | Mergers and Acquisitions Presentation Deck | 36 slides · Apollo
Conference presentation Investment bank Beat · Evidence & Proof1 hit
17
Apollo Global Management | Mergers and Acquisitions Presentation Deck | 36 slidesApollo Global Management | Mergers and Acquisitions Presentation Deck | 36 slides · Apollo
Conference presentation Investment bank Beat · Evidence & Proof1 hit
19
Apollo Global Management | Mergers and Acquisitions Presentation Deck | 36 slidesApollo Global Management | Mergers and Acquisitions Presentation Deck | 36 slides · Apollo
Conference presentation Investment bank Beat · Evidence & Proof1 hit
22
Apollo Global Management | Mergers and Acquisitions Presentation Deck | 36 slidesApollo Global Management | Mergers and Acquisitions Presentation Deck | 36 slides · Apollo
Conference presentation Investment bank Beat · Evidence & Proof1 hit
06
This slide serves as a core strategic thesis statement for Apollo.Apollo Global Management | Mergers and Acquisitions Presentation Deck | 48 slides · Apollo Global Management
Conference presentation Investment bank Beat · Situation & Context1 hit
07
Apollo Global Management | Mergers and Acquisitions Presentation Deck | 48 slidesApollo Global Management | Mergers and Acquisitions Presentation Deck | 48 slides · Apollo Global Management
Conference presentation Investment bank Beat · Situation & Context1 hit
25
Apollo Global Management | Mergers and Acquisitions Presentation Deck | 48 slidesApollo Global Management | Mergers and Acquisitions Presentation Deck | 48 slides · Apollo Global Management
Conference presentation Investment bank Beat · Solution & ApproachLoop · Before After1 hit
40
The slide uses a numbered list format to structure the valuation arguments.Apollo Global Management | Mergers and Acquisitions Presentation Deck | 48 slides · Apollo Global Management
Conference presentation Investment bank Beat · Evidence & Proof1 hit
03
argenx SE | Results Presentation Deck | 20 slidesargenx SE | Results Presentation Deck | 20 slides · argenx
Conference presentation Investor relations Beat · Humble Origins1 hit
06
The slide uses a series of four big-number metrics to communicate clinical efficacy.argenx SE | Results Presentation Deck | 20 slides · argenx
Conference presentation Investor relations Beat · Rising Success1 hit
13
The slide compares CR and CRc rates for ITT and patients with >= 2 cycles, while noting 30-day mortality and adverse risk classification.argenx SE | Results Presentation Deck | 20 slides · argenx
Conference presentation Investor relations 1 hit
10
The slide uses a three-column layout to present market data and strategic initiatives.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
11
AstraZeneca | Investor Day Presentation Deck | 86 slidesAstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
18
The slide uses a three-column layout to present project metrics, chemical safety improvements, and biological efficacy results.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations Loop · Hypothesis Test1 hit
21
The slide uses a four-column layout to present distinct technological approaches to clinical trial optimization.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations Loop · Hypothesis Test1 hit
25
AstraZeneca | Investor Day Presentation Deck | 86 slidesAstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
27
The slide uses a comparison structure between clinical trial data and real-world evidence.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
38
Slide presents data from PROMIS observational trial and SATELLITE Phase IIa trial.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations Beat · Market Size1 hit
53
Includes footnotes for clinical trial abbreviations and data sources.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
79
The slide uses a three-column layout to present distinct clinical trial outcomes.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
04
Includes footnote references for licensing and S1P definition.Bausch Health Companies | Investor Conference Presentation Deck | 10 slides · Bausch Health
Conference presentation Investor relations Beat · Product1 hit
09
The slide outlines the therapeutic rationale and clinical roadmap for a specific drug candidate.Bausch Health Companies | Investor Conference Presentation Deck | 10 slides · Bausch Health
Conference presentation Investor relations Beat · Solution1 hit
06
The slide uses a 2x3 grid layout to present organizational milestones.BioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · Key Takeaways1 hit
07
BioNTech | Results Presentation Deck | 36 slidesBioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · Key Takeaways1 hit
11
Includes citations for clinical trial data.BioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · RoadmapLoop · Why Now1 hit
12
The slide highlights vaccine efficacy metrics (97% and 94%) against various COVID-19 outcomes.BioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · RoadmapLoop · Why Now1 hit
13
BioNTech | Results Presentation Deck | 36 slidesBioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · Key MessagesLoop · Cost Of Inaction1 hit
09
Cano Health | SPAC Presentation Deck | 77 slidesCano Health | SPAC Presentation Deck | 77 slides · Cano Health
Conference presentation Investment bank Beat · Solution1 hit
21
The slide uses a 4-column layout to map strategic goals to specific quantitative outcomes.Cano Health | SPAC Presentation Deck | 77 slides · Cano Health
Conference presentation Investment bank Beat · AgitateLoop · Cost Of Inaction1 hit
22
Cano Health | SPAC Presentation Deck | 77 slidesCano Health | SPAC Presentation Deck | 77 slides · Cano Health
Conference presentation Investment bank 1 hit